Mycophenolic Acid (Myfortic)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
End Stage Renal Disease (ESRD)
Conditions
End Stage Renal Disease (ESRD)
Trial Timeline
Apr 1, 2006 → Jan 1, 2008
NCT ID
NCT00374803About Mycophenolic Acid (Myfortic)
Mycophenolic Acid (Myfortic) is a approved stage product being developed by Novartis for End Stage Renal Disease (ESRD). The current trial status is completed. This product is registered under clinical trial identifier NCT00374803. Target conditions include End Stage Renal Disease (ESRD).
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00619216 | Pre-clinical | Completed |
| NCT00374803 | Approved | Completed |
Competing Products
20 competing products in End Stage Renal Disease (ESRD)